Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,984 | -$3,738 | -$4,150 | -$4,659 |
| Dep. & Amort. | $164 | $132 | $138 | $142 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $520 | $451 | $838 |
| Change in WC | -$2,719 | $1,293 | $2,593 | -$394 |
| Other Non-Cash | $1,003 | $560 | $266 | $1,136 |
| Operating Cash Flow | -$3,536 | -$1,233 | -$702 | -$2,937 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$519 | -$265 | -$55 | -$245 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$519 | -$265 | -$55 | -$245 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$5 | -$5 | -$5 |
| Stock Issued | $49 | $0 | $0 | $6,776 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $30 | $30 | -$11 |
| Financing Cash Flow | $45 | $25 | $25 | $6,760 |
| Forex Effect | -$156 | -$237 | $2 | $150 |
| Net Chg. in Cash | -$4,166 | -$1,710 | -$730 | $3,728 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,301 | $31,011 | $31,741 | $28,013 |
| End Cash | $25,135 | $29,301 | $31,011 | $31,741 |
| Free Cash Flow | -$4,055 | -$1,498 | -$757 | -$3,182 |